What is Angiosarcoma?
Angiosarcoma is a rare and aggressive form of cancer that originates in the cells lining blood vessels. While it can develop in any part of the body, it is most commonly found in the skin, breasts, internal organs, bones, and deep tissues. In very rare cases, it can also occur in the heart. Angiosarcoma was first recognized in the late 19th and early 20th centuries as a rare form of vascular malignancy. Its identification became more defined with the development of histopathological techniques, allowing for better differentiation from other types of sarcomas and vascular tumors. Historically, angiosarcoma gained attention due to its association with environmental factors and certain medical conditions.
Causes and Risk Factors
The exact cause of most angiosarcomas remains unknown. However, certain factors are known to increase the risk, including:
Radiation exposure: Previous radiation therapy may lead to radiation-induced angiosarcoma.
Lymphedema: Swelling in the lymph nodes, often resulting from cancer treatment.
Chemical exposure: Contact with certain industrial chemicals.
Genetic conditions: Inherited syndromes may also play a role.
Researchers are actively studying these risk factors to better understand the causes of angiosarcoma.
Angiosarcoma Statistics
Angiosarcoma represents 4.16% of all soft tissue sarcomas and 0.05% of all cancers.
The median age at diagnosis is 71 years, and it is slightly more common in females.
Signs and Symptoms
The symptoms of angiosarcoma depend on the location and size of the tumor. Common signs include:
A lesion resembling a bruise that doesn’t heal and increases in size. A lesion that bleeds when disturbed. A rapidly growing, painful lump or swelling in soft tissue. As an aggressive cancer, angiosarcoma can spread to other parts of the body quickly.
Angiosarcoma Diagnosis
Diagnosis involves several tests:
Physical Examination: Checking for visible or palpable lumps.
Imaging: Scans such as X-ray, ultrasound, CT, MRI, or PET to identify the tumor.
Biopsy: A sample of the tumor is analyzed to confirm angiosarcoma.
Histological Characteristics
Angiosarcoma presents a wide histological spectrum:
- Well-differentiated Variants: Display irregular vascular channels lined by endothelial cells.
- Poorly Differentiated Variants: Show spindle, polygonal, or epithelioid cells with increased mitotic activity and poorly formed vascular spaces.
Poorly differentiated forms pose diagnostic challenges due to their heterogeneous appearance.
Immunohistochemical Markers
Immunohistochemistry aids in diagnosing poorly differentiated angiosarcoma:
Common endothelial markers include CD31, CD34, and VEGF. Among these, CD31 is the most reliable and sensitive marker.
Epithelioid angiosarcomas may express cytokeratin, complicating differentiation from poorly differentiated carcinomas.
Genetic Alterations
Research has uncovered genetic anomalies associated with angiosarcoma:
MYC Gene Amplification: Frequently found in secondary angiosarcomas, particularly those induced by radiation. Amplification is linked to UV and radiation exposure.
FLT4 Gene Alterations: Linked to lymphatic differentiation, FLT4 amplification is seen in about 25% of secondary angiosarcomas.
CIC Gene Rearrangements: Found in approximately 9% of primary cutaneous angiosarcomas.
PTPRB and PLCG1 Mutations: Identified as potential therapeutic targets due to their role in angiogenesis signaling.
These genetic insights not only enhance diagnostic precision but also inform emerging therapeutic approaches, such as targeting FLT4 and MYC amplification in secondary angiosarcomas.
Therapeutic Implications
Advances in genetic research underscore the potential for targeted therapies and personalized medicine in treating angiosarcoma. Continued studies into genetic pathways and molecular markers are pivotal for improving outcomes.
Treatment Options
Treatment depends on the tumor’s size, location, and whether it has spread.
Surgery: The primary treatment, where the tumor and surrounding tissue are removed. In some cases, limb-sparing surgery or mastectomy may be necessary.
Radiotherapy: High-energy radiation used to shrink tumors before surgery or destroy residual cancer cells afterward.
Chemotherapy: Anti-cancer drugs are used when surgery isn’t viable or if the cancer has spread.
Targeted and Experimental Therapies: Treatments like targeted therapy and immunotherapy are showing promise in clinical trials, though further research is needed.
After treatment, regular follow-ups are essential to monitor for recurrence. These may include:
Symptom discussions and physical exams. Imaging scans such as CT, MRI, or chest X-rays; Self-monitoring for local recurrence is also recommended.
Living with Angiosarcoma
Angiosarcoma can reappear in the same area (local recurrence) or spread to other parts of the body (metastasis), such as the lungs, lymph nodes, bones, liver, or brain. Prompt treatment is crucial in these cases.
Receiving an angiosarcoma diagnosis can be overwhelming, given its rarity and aggressive nature. It’s crucial to establish a robust support network, including medical professionals, family, friends, and patient advocacy groups. Counseling services and peer support communities can also provide emotional and psychological support.
Hope and Research
While angiosarcoma is rare and challenging to treat, ongoing research continues to improve understanding and develop new therapies. If you or a loved one are facing angiosarcoma, there is hope, and resources are available to support you.
Here is a page that provides an overview of sarcoma and its most common subtypes.
Resources:
Sarcoma.org.uk
PMC
E-acfs.org
